BioSyent, Inc. (RX.V)

12.05 +0.23 (+1.95%) CAD  |  TSXV  |  Dec 11, 16:00
More

BioSyent EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for RX.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Biocure Technology, Inc. Upgrade
Core One Labs, Inc. --
Restart Life Sciences Corp. Upgrade
NanoSphere Health Sciences, Inc. Upgrade
Lobe Sciences Ltd. Upgrade